MSB 2.51% 97.0¢ mesoblast limited

Ann: FDA Supports Accelerated Approval Pathway for Heart Failure, page-93

  1. 15,510 Posts.
    lightbulb Created with Sketch. 5587

    If you read the heading it doesn't say "may" ....Freudian slip perhaps but you would think the lawyers would be all over that ?

    ...... and of course if you read what I actually wrote in Post #:72838453 you would see that I acknowledge that it doesn't guarantee an AA .... but what it does tell us is the FDA are interested in an AA pathway for Rexlemestrocel-L due to it's stellar results - something all you naysayers have claimed for years wouldn't even get a look in due to supposed 'post hoc analysis' by Mesoblast ...

    upload_2024-3-11_11-42-55.png
    upload_2024-3-11_11-40-28.png
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
97.0¢
Change
-0.025(2.51%)
Mkt cap ! $1.107B
Open High Low Value Volume
97.0¢ $1.01 96.5¢ $7.757M 7.884M

Buyers (Bids)

No. Vol. Price($)
10 274918 97.0¢
 

Sellers (Offers)

Price($) Vol. No.
97.5¢ 974 1
View Market Depth
Last trade - 16.10pm 02/08/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.